OBJECTIVE: We aimed to compare glycemic control and pregnancy outcome in type I diabetic patients treated by 2 modes of treatment: multiple daily injections of insulin (MDI) and continuous subcutaneous insulin infusions (CSII). STUDY DESIGN: In a retrospective, matched-control study, patients treated by MDI were compared with patients treated by CSII in a ratio of 2:1. Level of glycemic control and pregnancy outcome was compared. RESULTS: Overall, 90 women were evaluated; of them 30 were treated by CSII and 60 by MDI. No between-group differences were found in maternal age, nulliparity rate, severity and duration of diabetes, prepregnancy body mass index, and weight gain during pregnancy. The rate of diabetic ketoacidosis (DKA) and neonatal hypoglycemia were significantly higher in the CSII group (13% vs 2%, P = .04) and (35% vs 13%, P = .01), respectively. No significant differences were found in pregnancy outcome measures. CONCLUSION: In type 1 diabetes, glycemic control and pregnancy outcome are compromised, regardless of treatment modality. CSII may be associated with higher rate of both maternal DKA and neonatal hypoglycemic events.
OBJECTIVE: We aimed to compare glycemic control and pregnancy outcome in type I diabeticpatients treated by 2 modes of treatment: multiple daily injections of insulin (MDI) and continuous subcutaneous insulin infusions (CSII). STUDY DESIGN: In a retrospective, matched-control study, patients treated by MDI were compared with patients treated by CSII in a ratio of 2:1. Level of glycemic control and pregnancy outcome was compared. RESULTS: Overall, 90 women were evaluated; of them 30 were treated by CSII and 60 by MDI. No between-group differences were found in maternal age, nulliparity rate, severity and duration of diabetes, prepregnancy body mass index, and weight gain during pregnancy. The rate of diabetic ketoacidosis (DKA) and neonatal hypoglycemia were significantly higher in the CSII group (13% vs 2%, P = .04) and (35% vs 13%, P = .01), respectively. No significant differences were found in pregnancy outcome measures. CONCLUSION: In type 1 diabetes, glycemic control and pregnancy outcome are compromised, regardless of treatment modality. CSII may be associated with higher rate of both maternal DKA and neonatal hypoglycemic events.
Authors: Marietta Stadler; Sandra Zlamal-Fortunat; Ingrid Schütz-Fuhrmann; Birgit Rami-Merhar; Elke Fröhlich-Reiterer; Sabine Hofer; Julia Mader; Michael Resl; Alexandra Kautzky-Willer; Raimund Weitgasser; Rudolf Prager; Martin Bischof Journal: Wien Klin Wochenschr Date: 2016-04 Impact factor: 1.704
Authors: Regina M Simeone; Owen J Devine; Jessica A Marcinkevage; Suzanne M Gilboa; Hilda Razzaghi; Barbara H Bardenheier; Andrea J Sharma; Margaret A Honein Journal: Am J Prev Med Date: 2014-10-14 Impact factor: 5.043
Authors: Melissa M Kallas-Koeman; Jason M Kong; Jennifer A Klinke; Sonia Butalia; Abhay K Lodha; Ken I Lim; Qiuli M Duan; Lois E Donovan Journal: Diabetologia Date: 2014-01-17 Impact factor: 10.122
Authors: K J Neff; R Forde; C Gavin; M M Byrne; R G R Firth; S Daly; F M McAuliffe; M Foley; M Coffey; S Coulter-Smith; B T Kinsley Journal: Ir J Med Sci Date: 2013-10-22 Impact factor: 1.568
Authors: Helen R Murphy; Daniela Elleri; Janet M Allen; Julie Harris; David Simmons; Gerry Rayman; Rosemary Temple; David B Dunger; Ahmad Haidar; Marianna Nodale; Malgorzata E Wilinska; Roman Hovorka Journal: Diabetes Care Date: 2011-01-07 Impact factor: 19.112
Authors: Denice S Feig; Elizabeth Asztalos; Rosa Corcoy; Alberto De Leiva; Lois Donovan; Moshe Hod; Lois Jovanovic; Erin Keely; Craig Kollman; Ruth McManus; Kellie Murphy; Katrina Ruedy; J Johanna Sanchez; George Tomlinson; Helen R Murphy Journal: BMC Pregnancy Childbirth Date: 2016-07-18 Impact factor: 3.007